Cargando…

Signaling Mechanism for Modulation by GLP-1 and Exendin-4 of GABA Receptors on Rat Retinal Ganglion Cells

Glucagon-like peptide-1 (GLP-1) is expressed in retinal neurons, but its role in the retina is largely unknown. Here, we demonstrated that GLP-1 or the GLP-1 receptor (GLP-1R; a G protein-coupled receptor) agonist exendin-4 suppressed γ-aminobutyric acid receptor (GABAR)-mediated currents through GL...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tao, Ruan, Hang-Ze, Wang, Yong-Chen, Shao, Yu-Qi, Zhou, Wei, Weng, Shi-Jun, Zhong, Yong-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206055/
https://www.ncbi.nlm.nih.gov/pubmed/35278196
http://dx.doi.org/10.1007/s12264-022-00826-9
Descripción
Sumario:Glucagon-like peptide-1 (GLP-1) is expressed in retinal neurons, but its role in the retina is largely unknown. Here, we demonstrated that GLP-1 or the GLP-1 receptor (GLP-1R; a G protein-coupled receptor) agonist exendin-4 suppressed γ-aminobutyric acid receptor (GABAR)-mediated currents through GLP-1Rs in isolated rat retinal ganglion cells (GCs). Pre-incubation with the stimulatory G protein (G(s)) inhibitor NF 449 abolished the exendin-4 effect. The exendin-4-induced suppression was mimicked by perfusion with 8-Br-cAMP (a cAMP analog), but was eliminated by the protein kinase A (PKA) inhibitor Rp-cAMP/KT-5720. The exendin-4 effect was accompanied by an increase in [Ca(2+)](i) of GCs through the IP(3)-sensitive pathway and was blocked in Ca(2+)-free solution. Furthermore, when the activity of calmodulin (CaM) and CaM-dependent protein kinase II (CaMKII) was inhibited, the exendin-4 effect was eliminated. Consistent with this, exendin-4 suppressed GABAR-mediated light-evoked inhibitory postsynaptic currents in GCs in rat retinal slices. These results suggest that exendin-4-induced suppression may be mediated by a distinct G(s)/cAMP-PKA/IP(3)/Ca(2+)/CaM/CaMKII signaling pathway, following the activation of GLP-1Rs. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s12264-022-00826-9) contains supplementary material, which is available to authorized users.